MedPath
TGA Approval

RAPIFEN alfentanil 1mg/2mL (as hydrochloride) injection, ampoule (50506)

50506

RAPIFEN alfentanil 1mg/2mL (as hydrochloride) injection, ampoule

Piramal Critical Care Pty Ltd

October 14, 1994

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/aa35ddaae9282b7e3f5a012b1047f8d7.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/2835c132603fc241ed0cfc3d67cf19cb.pdf

Active Ingredients

alfentanil hydrochloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

RAPIFEN alfentanil 1mg/2mL (as hydrochloride) injection, ampoule (50506) - TGA 批准文号 | MedPath